Progress in Cerebral Embolic Protection

 


 


Progress in Cerebral Embolic Protection


FACULTY:

Samir R. Kapadia, MD
Cleveland Clinic
Cleveland, OH		 Alexandra J. Lansky, MD
YCRG Yale School of Medicine
New Haven, CT

Pieter R. Stella, MD
University Medical Center Utrecht
Utrecht, The Netherlands
Raj Makkar, MD
Cedars-Sinai Medical Center
Los Angeles, CA		 Jeffrey W. Moses, MD
NewYork-Presbyterian/ Columbia University Medical Center
New York, NY		  






 

 

 

 

AGENDA: A Critical Review of the Neurological Effects of Invasive Cardiac Procedures: Do We Need to Do Better?
Pieter R. Stella, MD

The Search for Meaningful Measures of Clinical Efficacy: Neuro ARC and Beyond
Alexandra J. Lansky, MD

Practical Considerations and Design Requirements for Clinically Relevant CEP: The Keystone TriGuard 3 Device
Tamim Nazif, MD

Building the Evidence for CEP in TAVR: Critical Review of the Clinical Trial Data and REFLECT Update
Jeffrey W. Moses, MD

CEP Should Be Used Judiciously in Selected TAVR Patients Only
Raj Makkar, MD

CEP Is Necessary and Indicated for All TAVR Procedures
Samir R. Kapadia, MD

 

This program was supported by Keystone Heart:  Progress in Cerebral Embolic Protection